The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Peripheral Vascular Diseases
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
-
St. Bernard's Medical Center, Jonesboro, Arkansas, United States, 72401
PIH Health Good Samaritan Hospital, Los Angeles, California, United States, 90017
Cedars - Sinai Medical Center, Los Angeles, California, United States, 90048
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States, 90095
Sutter Medical Center, Sacramento, Sacramento, California, United States, 95816
Adventist Health St Helena Hospital, Saint Helena, California, United States, 94574
Yale University School of Medicine, New Haven, Connecticut, United States, 06510
Christiana Hospital, Newport, Delaware, United States, 19718
Washington Hospital Center, Washington, District of Columbia, United States, 20010
Palm Beach Heart & Vascular, LLC, Boynton Beach, Florida, United States, 33436
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Boston Scientific Corporation,
2028-01